Fulminanter Schub

Literatur

• 1 Hyde G M, Jewell D P. Review article: the management of severe ulcerative colitis.  Aliment Pharmacol Ther. 1997;  11 419-424 (III)
• 2 Marion J F, Present D H. The modern medical management of acute, severe ulcerative colitis.  Eur J Gastroenterol Hepatol. 1997;  9 831-835 (IV)
• 3 Truelove S C, Witts L J. Corisone in ulcerative colitis.  Br Med J. 1955;  2 1041-1048 (IIa)
• 4 Carbonnel F, Lavergne A, Lemann M. et al . Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.  Dig Dis Sci. 1994;  39 1550-1557 (III)
• 5 Carbonnel F, Gargouri D, Lemann M. et al . Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis.  Aliment Pharmacol Ther. 2000;  14 273-279 (IIb)
• 6 Powell-Tuck J, Day D W, Buckell N A. et al . Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.  Dig Dis Sci. 1982;  27 533-537 (III)
• 7 Chew C N, Nolan D J, Jewell D P. Small bowel gas in severe ulcerative colitis.  Gut. 1991;  32 1535-1537 (III)
• 8 Latella G, Vernia P, Viscido A. et al . GI distension in severe ulcerative colitis.  Am J Gastroenterol. 2002;  97 1169-1175 (IIb)
• 9 Almer S, Bodemar G, Franzen L. et al . Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis.  Lancet. 1996;  347 1731-1735 (III)
• 10 Chaudhuri A, Bekdash B A. Toxic megacolon due to Salmonella: a case report and review of the literature.  Int J Colorectal Dis. 2002;  17 275-279 (IV)
• 11 Dallal R M, Harbrecht B G, Boujoukas A J. et al . Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.  Ann Surg. 2002;  235 363-372 (III)
• 12 Medich D S, Lee K K, Simmons R L. et al . Laparotomy for fulminant pseudomembranous colitis.  Arch Surg. 1992;  127: 847 - 852; discussion 852 - 853 (III)
• 13 Kaufman H S, Kahn A C, Iacobuzio-Donahue C. et al . Cytomegaloviral enterocolitis: clinical associations and outcome.  Dis Colon Rectum. 1999;  42 24-30 (III)
• 14 Rahbar A, Bostrom L, Lagerstedt U. et al . Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases.  Inflamm Bowel Dis. 2003;  9 154-161 (IIb)
• 15 Papadakis K A, Tung J K, Binder S W. et al . Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.  Am J Gastroenterol. 2001;  96 2137-2142 (III)
• 16 Adani G L, Avital I, Ferraresso C. et al . CMV infection in severe refractory ulcerative and Crohn’s colitis.  Am J Gastroenterol. 2001;  96 3464-3465 (IV)
• 17 Cooper H S, Raffensperger E C, Jonas L. et al . Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection.  Gastroenterology. 1977;  72 1253-1256 (III)
• 18 Aristizabal H, Acevedo J, Botero M. Fulminant amebic colitis.  World J Surg. 1991;  15 216-221 (IV)
• 19 Meyers S, Lerer P K, Feuer E J. et al . Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial.  J Clin Gastroenterol. 1987;  9 50-54 (III)
• 20 Kornbluth A, Present D H, Lichtiger S. et al . Cyclosporin for severe ulcerative colitis: a user’s guide.  Am J Gastroenterol. 1997;  92 1424-1428 (IV)
• 21 Lindgren S C, Flood L M, Kilander A F. et al . Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis.  Eur J Gastroenterol Hepatol. 1998;  10 831-835 (III)
• 22 Travis S P, Farrant J M, Ricketts C. et al . Predicting outcome in severe ulcerative colitis.  Gut. 1996;  38 905-910 (III)
• 23 Banez A V, Yamanishi F, Crans C A. Endoscopic colonic decompression of toxic megacolon, placement of colonic tube, and steroid colonclysis.  Am J Gastroenterol. 1987;  82 692-694 (IV)
• 24 Present D H, Wolfson D, Gelernt I M. et al . Medical decompression of toxic megacolon by „rolling”. A new technique of decompression with favorable long-term follow-up.  J Clin Gastroenterol. 1988;  10 485-490 (III)
• 25 Riedler L, Wohlgenannt D, Stoss F. et al . Endoscopic decompression in „toxic megacolon”.  Surg Endosc. 1989;  3 51-53 (IV)
• 26 Lichtiger S, Present D H, Kornbluth A. et al . Cyclosporine in severe ulcerative colitis refractory to steroid therapy.  N Engl J Med. 1994;  330 1841-1845 (Ib)
• 27 Meyers S, Sachar D B, Goldberg J D. et al . Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial.  Gastroenterology. 1983;  85 351-357 (Ib)
• 28 Oshitani N, Kitano A, Matsumoto T. et al . Corticosteroids for the management of ulcerative colitis.  J Gastroenterol. 1995;  30 (Suppl 8) 118-120 (IIa)
• 29 Jarnerot G, Rolny P, Sandberg-Gertzen H. Intensive intravenous treatment of ulcerative colitis.  Gastroenterology. 1985;  89 1005-1013 (III)
• 30 Truelove S C, Willoughby C P, Lee E G. et al . Further experience in the treatment of severe attacks of ulcerative colitis.  Lancet. 1978;  2 1086-1088 (IIb)
• 31 Hyde G M, Thillainayagam A V, Jewell D P. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?.  Eur J Gastroenterol Hepatol. 1998;  10 411-413 (III)
• 32 Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effect of prolonging the treatment.  Scand J Gastroenterol. 1993;  28 821-826 (IIb)
• 33 D’Haens G, Lemmens L, Geboes K. et al . Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.  Gastroenterology. 2001;  120 1323-1329 (Ib)
• 34 McIntyre P B, Powell-Tuck J, Wood S R. et al . Controlled trial of bowel rest in the treatment of severe acute colitis.  Gut. 1986;  27 481-485 (Ib)
• 35 Dickinson R J, Ashton M G, Axon A T. et al . Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis.  Gastroenterology. 1980;  79 1199-1204 (Ib)
• 36 Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M. et al . Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.  Am J Gastroenterol. 1993;  88 227-232 (Ib)
• 37 Seo M, Okada M, Yao T. et al . The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease.  J Clin Gastroenterol. 1999;  29 270-275 (IIb)
• 38 Chapman R W, Selby W S, Jewell D P. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.  Gut. 1986;  27 1210-1212 (Ib)
• 39 Dickinson R J, O’Connor H J, Pinder I. et al . Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.  Gut. 1985;  26 1380-1384 (Ib)
• 40 Mantzaris G J, Hatzis A, Kontogiannis P. et al . Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis.  Am J Gastroenterol. 1994;  89 43-46 (Ib)
• 41 Mantzaris G J, Petraki K, Archavlis E. et al . A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis.  Scand J Gastroenterol. 2001;  36 971-974 (Ib)
• 42 Van Assche G, D’Haens G, Noman M. et al . Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.  Gastroenterology. 2003;  125 1025-1031 (IIb)
• 43 Carbonnel F, Boruchowicz A, Duclos B. et al . Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses.  Dig Dis Sci. 1996;  41 2471-2476 (IIb)
• 44 Wenzl H H, Petritsch W, Aichbichler B W. et al . Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.  Z Gastroenterol. 1998;  36 287-293 (IIb)
• 45 Stack W A, Long R G, Hawkey C J. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.  Aliment Pharmacol Ther. 1998;  12 973-978 (IIb)
• 46 Cohen R D, Stein R, Hanauer S B. Intravenous cyclosporin in ulcerative colitis: a five-year experience.  Am J Gastroenterol. 1999;  94 1587-1592 (IIb)
• 47 Gijtenbeek J M, van den Bent M J, Vecht C J. Cyclosporine neurotoxicity: a review.  J Neurol. 1999;  246 339-346 (IV)
• 48 Actis G C. Cyclosporin for steroid-refractory ulcerative colitis.  Am J Gastroenterol. 2000;  95 830 (III)
• 49 Actis G C, Volpes R, Rizzetto M. Oral microemulsion cyclosporin to reduce steroids rapidly in chronic active ulcerative colitis.  Eur J Gastroenterol Hepatol. 1999;  11 905-908 (IIb)
• 50 Actis G C, Aimo G, Priolo G. et al . Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial.  Inflamm Bowel Dis. 1998;  4 276-279 (IIb)
• 51 Baumgart D C, Wiedenmann B, Dignass A U. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease.  Aliment Pharmacol Ther. 2003;  17 1273-1281 (III)
• 52 Fellermann K, Tanko Z, Herrlinger K R. et al . Response of refractory colitis to intravenous or oral tacrolimus (FK506).  Inflamm Bowel Dis. 2002;  8 317-324 (III)
• 53 Fellermann K, Ludwig D, Stahl M. et al . Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).  Am J Gastroenterol. 1998;  93 1860-1866 (IIb)
• 54 Bousvaros A, Kirschner B S, Werlin S L. et al . Oral tacrolimus treatment of severe colitis in children.  J Pediatr. 2000;  137 794-799 (III)
• 55 Bousvaros A, Wang A, Leichtner A M. Tacrolimus (FK-506) treatment of fulminant colitis in a child.  J Pediatr Gastroenterol Nutr. 1996;  23 329-333 (IV)
• 56 Fernandez-Banares F, Bertran X, Esteve-Comas M. et al . Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.  Am J Gastroenterol. 1996;  91 2498-2499 (IIb)
• 57 George J, Present D H, Pou R. et al . The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.  Am J Gastroenterol. 1996;  91 1711-1714 (III)
• 58 Sood A, Kaushal V, Midha V. et al . The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis.  J Gastroenterol. 2002;  37 270-274 (IIa)
• 59 Domenech E, Garcia-Planella E, Bernal I. et al . Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.  Aliment Pharmacol Ther. 2002;  16 2061-2065 (III)
• 60 Actis G C, Bresso F, Astegiano M. et al . Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis.  Aliment Pharmacol Ther. 2001;  15 1307-1311 (III)
• 61 Kader H A, Mascarenhas M R, Piccoli D A. et al . Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.  J Pediatr Gastroenterol Nutr. 1999;  28 54-58 (III)
• 62 Sood A, Midha V, Sood N. et al . Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial.  Indian J Gastroenterol. 2000;  19 14-16 (Ib)
• 63 Higgins R M, Bloom S L, Hopkin J M. et al . The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation.  Transplantation. 1989;  47 558-560 (Ib)
• 64 Hyde G M, Jewell D P, Kettlewell M G. et al . Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications.  Dis Colon Rectum. 2001;  44 1436-1440 (IIb)
• 65 Treem W R, Davis P M, Hyams J S. Cyclosporine treatment of severe ulcerative colitis in children.  J Pediatr. 1991;  119 994-997 (IIb)
• 66 Ramakrishna J, Langhans N, Calenda K. et al . Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.  J Pediatr Gastroenterol Nutr. 1996;  22 296-302 (III)
• 67 Probert C S, Hearing S D, Schreiber S. et al . Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.  Gut. 2003;  52 998-1002 (Ib)
• 68 Sawada K, Muto T, Shimoyama T. et al . Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.  Curr Pharm Des. 2003;  9 307-321 (Ib)
• 69 Jo Y, Matsumoto T, Mibu R Iida M. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?.  Dis Colon Rectum. 2003;  46 3-9 (III)